Hydroxychloroquine (Plaquenil) Toxicity - Advanced
|
|
78 year old female No visual complaints referred for evaluation
Medical Hx: Rheumatoid Arthritis. Atrial Fibrillation. Benign Intracranial Hypertension. Sjogrens Syndrome. Osteoporosis.
Systemic Meds: PLAQUENIL (Stopped 2 months ago). Leflunomide. Lidocaine. Gabapentin. Vitamin D. Multaq. DILTIAZEM.
VA OD: Dcc20/32-2 NccJ2
VA OS: Dcc20/25+1 NccJ1-1
IOP: TP: OD:14 OS:15
Color Ishihara OD 9/11 correct, OS 9.5/11 correct
Weight 100 lbs, Height 4’ 2†tall.
1993 Plaquenil Initially 400 mg /day (9 mg/kg/day x 18 years) then 2011 200 mg daily - (4.6 mg/kg/day x 10 years) STOPPED 3/2021
The patient weighs 100 lbs and is 4’ 2†tall - Images are from 3/2021 and 5/2022
There was no progression 1 year after stopping plaquenil in this patient.
|

Hydroxychloroquine (plaquenil) Toxicity - Advancedvaatamisi: 25078 year old female No visual complaints referred for evaluation
Medical Hx: Rheumatoid Arthritis. Atrial Fibrillation. Benign Intracranial Hypertension. Sjogrens Syndrome. Osteoporosis.
Systemic Meds: PLAQUENIL (Stopped 2 months ago). Leflunomide. Lidocaine. Gabapentin. Vitamin D. Multaq. DILTIAZEM.
VA OD: Dcc20/32-2 NccJ2
VA OS: Dcc20/25+1 NccJ1-1
IOP: TP: OD:14 OS:15
Color Ishihara OD 9/11 correct, OS 9.5/11 correct
Weight 100 lbs, Height 4’ 2†tall.
1993 Plaquenil Initially 400 mg /day (9 mg/kg/day x 18 years) then 2011 200 mg daily - (4.6 mg/kg/day x 10 years) STOPPED 3/2021
The patient weighs 100 lbs and is 4’ 2†tall - Images are from 3/2021 and 5/2022
There was no progression 1 year after stopping plaquenil in this patient.     (0 hinnangut)
|
|

Hydroxychloroquine (plaquenil) Toxicity - Advancedvaatamisi: 22878 year old female No visual complaints referred for evaluation
Medical Hx: Rheumatoid Arthritis. Atrial Fibrillation. Benign Intracranial Hypertension. Sjogrens Syndrome. Osteoporosis.
Systemic Meds: PLAQUENIL (Stopped 2 months ago). Leflunomide. Lidocaine. Gabapentin. Vitamin D. Multaq. DILTIAZEM.
VA OD: Dcc20/32-2 NccJ2
VA OS: Dcc20/25+1 NccJ1-1
IOP: TP: OD:14 OS:15
Color Ishihara OD 9/11 correct, OS 9.5/11 correct
Weight 100 lbs, Height 4’ 2†tall.
1993 Plaquenil Initially 400 mg /day (9 mg/kg/day x 18 years) then 2011 200 mg daily - (4.6 mg/kg/day x 10 years) STOPPED 3/2021
The patient weighs 100 lbs and is 4’ 2†tall - Images are from 3/2021 and 5/2022
There was no progression 1 year after stopping plaquenil in this patient.     (0 hinnangut)
|
|

Hydroxychloroquine (plaquenil) Toxicity - Advancedvaatamisi: 22378 year old female No visual complaints referred for evaluation
Medical Hx: Rheumatoid Arthritis. Atrial Fibrillation. Benign Intracranial Hypertension. Sjogrens Syndrome. Osteoporosis.
Systemic Meds: PLAQUENIL (Stopped 2 months ago). Leflunomide. Lidocaine. Gabapentin. Vitamin D. Multaq. DILTIAZEM.
VA OD: Dcc20/32-2 NccJ2
VA OS: Dcc20/25+1 NccJ1-1
IOP: TP: OD:14 OS:15
Color Ishihara OD 9/11 correct, OS 9.5/11 correct
Weight 100 lbs, Height 4’ 2†tall.
1993 Plaquenil Initially 400 mg /day (9 mg/kg/day x 18 years) then 2011 200 mg daily - (4.6 mg/kg/day x 10 years) STOPPED 3/2021
The patient weighs 100 lbs and is 4’ 2†tall - Images are from 3/2021 and 5/2022
There was no progression 1 year after stopping plaquenil in this patient.     (0 hinnangut)
|
|

Hydroxychloroquine (plaquenil) Toxicity - Advancedvaatamisi: 23278 year old female No visual complaints referred for evaluation
Medical Hx: Rheumatoid Arthritis. Atrial Fibrillation. Benign Intracranial Hypertension. Sjogrens Syndrome. Osteoporosis.
Systemic Meds: PLAQUENIL (Stopped 2 months ago). Leflunomide. Lidocaine. Gabapentin. Vitamin D. Multaq. DILTIAZEM.
VA OD: Dcc20/32-2 NccJ2
VA OS: Dcc20/25+1 NccJ1-1
IOP: TP: OD:14 OS:15
Color Ishihara OD 9/11 correct, OS 9.5/11 correct
Weight 100 lbs, Height 4’ 2†tall.
1993 Plaquenil Initially 400 mg /day (9 mg/kg/day x 18 years) then 2011 200 mg daily - (4.6 mg/kg/day x 10 years) STOPPED 3/2021
The patient weighs 100 lbs and is 4’ 2†tall - Images are from 3/2021 and 5/2022
There was no progression 1 year after stopping plaquenil in this patient.     (0 hinnangut)
|
|

Hydroxychloroquine (plaquenil) Toxicity - Advancedvaatamisi: 25378 year old female No visual complaints referred for evaluation
Medical Hx: Rheumatoid Arthritis. Atrial Fibrillation. Benign Intracranial Hypertension. Sjogrens Syndrome. Osteoporosis.
Systemic Meds: PLAQUENIL (Stopped 2 months ago). Leflunomide. Lidocaine. Gabapentin. Vitamin D. Multaq. DILTIAZEM.
VA OD: Dcc20/32-2 NccJ2
VA OS: Dcc20/25+1 NccJ1-1
IOP: TP: OD:14 OS:15
Color Ishihara OD 9/11 correct, OS 9.5/11 correct
Weight 100 lbs, Height 4’ 2†tall.
1993 Plaquenil Initially 400 mg /day (9 mg/kg/day x 18 years) then 2011 200 mg daily - (4.6 mg/kg/day x 10 years) STOPPED 3/2021
The patient weighs 100 lbs and is 4’ 2†tall - Images are from 3/2021 and 5/2022
There was no progression 1 year after stopping plaquenil in this patient.     (0 hinnangut)
|
|

Hydroxychloroquine (plaquenil) Toxicity - Advancedvaatamisi: 24278 year old female No visual complaints referred for evaluation
Medical Hx: Rheumatoid Arthritis. Atrial Fibrillation. Benign Intracranial Hypertension. Sjogrens Syndrome. Osteoporosis.
Systemic Meds: PLAQUENIL (Stopped 2 months ago). Leflunomide. Lidocaine. Gabapentin. Vitamin D. Multaq. DILTIAZEM.
VA OD: Dcc20/32-2 NccJ2
VA OS: Dcc20/25+1 NccJ1-1
IOP: TP: OD:14 OS:15
Color Ishihara OD 9/11 correct, OS 9.5/11 correct
Weight 100 lbs, Height 4’ 2†tall.
1993 Plaquenil Initially 400 mg /day (9 mg/kg/day x 18 years) then 2011 200 mg daily - (4.6 mg/kg/day x 10 years) STOPPED 3/2021
The patient weighs 100 lbs and is 4’ 2†tall - Images are from 3/2021 and 5/2022
There was no progression 1 year after stopping plaquenil in this patient.     (0 hinnangut)
|
|

Hydroxychloroquine (plaquenil) Toxicity - Advancedvaatamisi: 25378 year old female No visual complaints referred for evaluation
Medical Hx: Rheumatoid Arthritis. Atrial Fibrillation. Benign Intracranial Hypertension. Sjogrens Syndrome. Osteoporosis.
Systemic Meds: PLAQUENIL (Stopped 2 months ago). Leflunomide. Lidocaine. Gabapentin. Vitamin D. Multaq. DILTIAZEM.
VA OD: Dcc20/32-2 NccJ2
VA OS: Dcc20/25+1 NccJ1-1
IOP: TP: OD:14 OS:15
Color Ishihara OD 9/11 correct, OS 9.5/11 correct
Weight 100 lbs, Height 4’ 2†tall.
1993 Plaquenil Initially 400 mg /day (9 mg/kg/day x 18 years) then 2011 200 mg daily - (4.6 mg/kg/day x 10 years) STOPPED 3/2021
The patient weighs 100 lbs and is 4’ 2†tall - Images are from 3/2021 and 5/2022
There was no progression 1 year after stopping plaquenil in this patient.     (0 hinnangut)
|
|

Hydroxychloroquine (plaquenil) Toxicity - Advancedvaatamisi: 23778 year old female No visual complaints referred for evaluation
Medical Hx: Rheumatoid Arthritis. Atrial Fibrillation. Benign Intracranial Hypertension. Sjogrens Syndrome. Osteoporosis.
Systemic Meds: PLAQUENIL (Stopped 2 months ago). Leflunomide. Lidocaine. Gabapentin. Vitamin D. Multaq. DILTIAZEM.
VA OD: Dcc20/32-2 NccJ2
VA OS: Dcc20/25+1 NccJ1-1
IOP: TP: OD:14 OS:15
Color Ishihara OD 9/11 correct, OS 9.5/11 correct
Weight 100 lbs, Height 4’ 2†tall.
1993 Plaquenil Initially 400 mg /day (9 mg/kg/day x 18 years) then 2011 200 mg daily - (4.6 mg/kg/day x 10 years) STOPPED 3/2021
The patient weighs 100 lbs and is 4’ 2†tall - Images are from 3/2021 and 5/2022
There was no progression 1 year after stopping plaquenil in this patient.     (0 hinnangut)
|
|

Hydroxychloroquine (plaquenil) Toxicity - Advancedvaatamisi: 20678 year old female No visual complaints referred for evaluation
Medical Hx: Rheumatoid Arthritis. Atrial Fibrillation. Benign Intracranial Hypertension. Sjogrens Syndrome. Osteoporosis.
Systemic Meds: PLAQUENIL (Stopped 2 months ago). Leflunomide. Lidocaine. Gabapentin. Vitamin D. Multaq. DILTIAZEM.
VA OD: Dcc20/32-2 NccJ2
VA OS: Dcc20/25+1 NccJ1-1
IOP: TP: OD:14 OS:15
Color Ishihara OD 9/11 correct, OS 9.5/11 correct
Weight 100 lbs, Height 4’ 2†tall.
1993 Plaquenil Initially 400 mg /day (9 mg/kg/day x 18 years) then 2011 200 mg daily - (4.6 mg/kg/day x 10 years) STOPPED 3/2021
The patient weighs 100 lbs and is 4’ 2†tall - Images are from 3/2021 and 5/2022
There was no progression 1 year after stopping plaquenil in this patient.     (0 hinnangut)
|
|

Hydroxychloroquine (plaquenil) Toxicity - Advancedvaatamisi: 22478 year old female No visual complaints referred for evaluation
Medical Hx: Rheumatoid Arthritis. Atrial Fibrillation. Benign Intracranial Hypertension. Sjogrens Syndrome. Osteoporosis.
Systemic Meds: PLAQUENIL (Stopped 2 months ago). Leflunomide. Lidocaine. Gabapentin. Vitamin D. Multaq. DILTIAZEM.
VA OD: Dcc20/32-2 NccJ2
VA OS: Dcc20/25+1 NccJ1-1
IOP: TP: OD:14 OS:15
Color Ishihara OD 9/11 correct, OS 9.5/11 correct
Weight 100 lbs, Height 4’ 2†tall.
1993 Plaquenil Initially 400 mg /day (9 mg/kg/day x 18 years) then 2011 200 mg daily - (4.6 mg/kg/day x 10 years) STOPPED 3/2021
The patient weighs 100 lbs and is 4’ 2†tall - Images are from 3/2021 and 5/2022
There was no progression 1 year after stopping plaquenil in this patient.     (0 hinnangut)
|
|

Hydroxychloroquine (plaquenil) Toxicity - Advancedvaatamisi: 22078 year old female No visual complaints referred for evaluation
Medical Hx: Rheumatoid Arthritis. Atrial Fibrillation. Benign Intracranial Hypertension. Sjogrens Syndrome. Osteoporosis.
Systemic Meds: PLAQUENIL (Stopped 2 months ago). Leflunomide. Lidocaine. Gabapentin. Vitamin D. Multaq. DILTIAZEM.
VA OD: Dcc20/32-2 NccJ2
VA OS: Dcc20/25+1 NccJ1-1
IOP: TP: OD:14 OS:15
Color Ishihara OD 9/11 correct, OS 9.5/11 correct
Weight 100 lbs, Height 4’ 2†tall.
1993 Plaquenil Initially 400 mg /day (9 mg/kg/day x 18 years) then 2011 200 mg daily - (4.6 mg/kg/day x 10 years) STOPPED 3/2021
The patient weighs 100 lbs and is 4’ 2†tall - Images are from 3/2021 and 5/2022
There was no progression 1 year after stopping plaquenil in this patient.     (0 hinnangut)
|
|

Hydroxychloroquine (plaquenil) Toxicity - Advancedvaatamisi: 21978 year old female No visual complaints referred for evaluation
Medical Hx: Rheumatoid Arthritis. Atrial Fibrillation. Benign Intracranial Hypertension. Sjogrens Syndrome. Osteoporosis.
Systemic Meds: PLAQUENIL (Stopped 2 months ago). Leflunomide. Lidocaine. Gabapentin. Vitamin D. Multaq. DILTIAZEM.
VA OD: Dcc20/32-2 NccJ2
VA OS: Dcc20/25+1 NccJ1-1
IOP: TP: OD:14 OS:15
Color Ishihara OD 9/11 correct, OS 9.5/11 correct
Weight 100 lbs, Height 4’ 2†tall.
1993 Plaquenil Initially 400 mg /day (9 mg/kg/day x 18 years) then 2011 200 mg daily - (4.6 mg/kg/day x 10 years) STOPPED 3/2021
The patient weighs 100 lbs and is 4’ 2†tall - Images are from 3/2021 and 5/2022
There was no progression 1 year after stopping plaquenil in this patient.     (0 hinnangut)
|
|

Hydroxychloroquine (plaquenil) Toxicity - Advancedvaatamisi: 25478 year old female No visual complaints referred for evaluation
Medical Hx: Rheumatoid Arthritis. Atrial Fibrillation. Benign Intracranial Hypertension. Sjogrens Syndrome. Osteoporosis.
Systemic Meds: PLAQUENIL (Stopped 2 months ago). Leflunomide. Lidocaine. Gabapentin. Vitamin D. Multaq. DILTIAZEM.
VA OD: Dcc20/32-2 NccJ2
VA OS: Dcc20/25+1 NccJ1-1
IOP: TP: OD:14 OS:15
Color Ishihara OD 9/11 correct, OS 9.5/11 correct
Weight 100 lbs, Height 4’ 2†tall.
1993 Plaquenil Initially 400 mg /day (9 mg/kg/day x 18 years) then 2011 200 mg daily - (4.6 mg/kg/day x 10 years) STOPPED 3/2021
The patient weighs 100 lbs and is 4’ 2†tall - Images are from 3/2021 and 5/2022
There was no progression 1 year after stopping plaquenil in this patient.     (0 hinnangut)
|
|

Hydroxychloroquine (plaquenil) Toxicity - Advancedvaatamisi: 21478 year old female No visual complaints referred for evaluation
Medical Hx: Rheumatoid Arthritis. Atrial Fibrillation. Benign Intracranial Hypertension. Sjogrens Syndrome. Osteoporosis.
Systemic Meds: PLAQUENIL (Stopped 2 months ago). Leflunomide. Lidocaine. Gabapentin. Vitamin D. Multaq. DILTIAZEM.
VA OD: Dcc20/32-2 NccJ2
VA OS: Dcc20/25+1 NccJ1-1
IOP: TP: OD:14 OS:15
Color Ishihara OD 9/11 correct, OS 9.5/11 correct
Weight 100 lbs, Height 4’ 2†tall.
1993 Plaquenil Initially 400 mg /day (9 mg/kg/day x 18 years) then 2011 200 mg daily - (4.6 mg/kg/day x 10 years) STOPPED 3/2021
The patient weighs 100 lbs and is 4’ 2†tall - Images are from 3/2021 and 5/2022
There was no progression 1 year after stopping plaquenil in this patient.     (0 hinnangut)
|
|

Hydroxychloroquine (plaquenil) Toxicity - Advancedvaatamisi: 23478 year old female No visual complaints referred for evaluation
Medical Hx: Rheumatoid Arthritis. Atrial Fibrillation. Benign Intracranial Hypertension. Sjogrens Syndrome. Osteoporosis.
Systemic Meds: PLAQUENIL (Stopped 2 months ago). Leflunomide. Lidocaine. Gabapentin. Vitamin D. Multaq. DILTIAZEM.
VA OD: Dcc20/32-2 NccJ2
VA OS: Dcc20/25+1 NccJ1-1
IOP: TP: OD:14 OS:15
Color Ishihara OD 9/11 correct, OS 9.5/11 correct
Weight 100 lbs, Height 4’ 2†tall.
1993 Plaquenil Initially 400 mg /day (9 mg/kg/day x 18 years) then 2011 200 mg daily - (4.6 mg/kg/day x 10 years) STOPPED 3/2021
The patient weighs 100 lbs and is 4’ 2†tall - Images are from 3/2021 and 5/2022
There was no progression 1 year after stopping plaquenil in this patient.     (0 hinnangut)
|
|

Hydroxychloroquine (plaquenil) Toxicity - Advancedvaatamisi: 21278 year old female No visual complaints referred for evaluation
Medical Hx: Rheumatoid Arthritis. Atrial Fibrillation. Benign Intracranial Hypertension. Sjogrens Syndrome. Osteoporosis.
Systemic Meds: PLAQUENIL (Stopped 2 months ago). Leflunomide. Lidocaine. Gabapentin. Vitamin D. Multaq. DILTIAZEM.
VA OD: Dcc20/32-2 NccJ2
VA OS: Dcc20/25+1 NccJ1-1
IOP: TP: OD:14 OS:15
Color Ishihara OD 9/11 correct, OS 9.5/11 correct
Weight 100 lbs, Height 4’ 2†tall.
1993 Plaquenil Initially 400 mg /day (9 mg/kg/day x 18 years) then 2011 200 mg daily - (4.6 mg/kg/day x 10 years) STOPPED 3/2021
The patient weighs 100 lbs and is 4’ 2†tall - Images are from 3/2021 and 5/2022
There was no progression 1 year after stopping plaquenil in this patient.     (0 hinnangut)
|
|

Hydroxychloroquine (plaquenil) Toxicity - Advancedvaatamisi: 21978 year old female No visual complaints referred for evaluation
Medical Hx: Rheumatoid Arthritis. Atrial Fibrillation. Benign Intracranial Hypertension. Sjogrens Syndrome. Osteoporosis.
Systemic Meds: PLAQUENIL (Stopped 2 months ago). Leflunomide. Lidocaine. Gabapentin. Vitamin D. Multaq. DILTIAZEM.
VA OD: Dcc20/32-2 NccJ2
VA OS: Dcc20/25+1 NccJ1-1
IOP: TP: OD:14 OS:15
Color Ishihara OD 9/11 correct, OS 9.5/11 correct
Weight 100 lbs, Height 4’ 2†tall.
1993 Plaquenil Initially 400 mg /day (9 mg/kg/day x 18 years) then 2011 200 mg daily - (4.6 mg/kg/day x 10 years) STOPPED 3/2021
The patient weighs 100 lbs and is 4’ 2†tall - Images are from 3/2021 and 5/2022
There was no progression 1 year after stopping plaquenil in this patient.     (0 hinnangut)
|
|
|
|
|
|
|
78 year old female No visual complaints referred for evaluation
Medical Hx: Rheumatoid Arthritis. Atrial Fibrillation. Benign Intracranial Hypertension. Sjogrens Syndrome. Osteoporosis.
Systemic Meds: PLAQUENIL (Stopped 2 months ago). Leflunomide. Lidocaine. Gabapentin. Vitamin D. Multaq. DILTIAZEM.
VA OD: Dcc20/32-2 NccJ2
VA OS: Dcc20/25+1 NccJ1-1
IOP: TP: OD:14 OS:15
Color Ishihara OD 9/11 correct, OS 9.5/11 correct
Weight 100 lbs, Height 4’ 2†tall.
1993 Plaquenil Initially 400 mg /day (9 mg/kg/day x 18 years) then 2011 200 mg daily - (4.6 mg/kg/day x 10 years) STOPPED 3/2021
The patient weighs 100 lbs and is 4’ 2†tall - Images are from 3/2021 and 5/2022
There was no progression 1 year after stopping plaquenil in this patient.